| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.74B | 10.70B | 8.34B | 19.82B | 16.83B |
| Gross Profit | 1.63B | 2.82B | 1.16B | 10.42B | 8.18B |
| EBITDA | 2.16B | 3.06B | 2.26B | 10.95B | 7.97B |
| Net Income | 1.52B | 2.58B | 1.37B | 9.97B | 7.13B |
Balance Sheet | |||||
| Total Assets | 17.67B | 17.77B | 15.61B | 20.04B | 15.85B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 7.92B | 6.74B | 11.26B | 7.27B |
| Total Debt | 1.28B | 1.37B | 1.44B | 2.08B | 2.69B |
| Total Liabilities | 4.26B | 4.52B | 4.40B | 6.60B | 6.18B |
| Stockholders Equity | 13.41B | 13.25B | 11.21B | 13.44B | 9.67B |
Cash Flow | |||||
| Free Cash Flow | 314.82M | 1.95B | -760.89M | 10.73B | 8.32B |
| Operating Cash Flow | 2.33B | 3.21B | 617.20M | 11.25B | 8.90B |
| Investing Cash Flow | -2.88B | 2.51B | -4.64B | 1.42B | -1.98B |
| Financing Cash Flow | -2.01B | -1.20B | -4.29B | -7.12B | -4.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$256.44B | 6.39 | 13.13% | 12.48% | 30.56% | 108.49% | |
82 Outperform | HK$93.20B | 7.76 | 48.55% | 9.80% | 37.68% | 127.44% | |
79 Outperform | HK$62.17B | 4.19 | 6.63% | 5.72% | 9.00% | -4.33% | |
74 Outperform | HK$20.55B | 8.82 | 5.04% | 4.97% | 7.26% | 6.73% | |
73 Outperform | HK$13.39B | 5.38 | 18.24% | 10.40% | ― | ― | |
71 Outperform | HK$91.46B | 7.02 | 11.33% | 12.81% | 28.91% | 150.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |